Skip to main content

Table 3 The subset of metabolites having significantly different concentrations between SS and SNS groups at either clinical time points

From: Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS

  

Sepsis survivors (number = 90)

Sepsis non-survivors (number = 31)

LPS (number = 15)

Metabolite name

Super pathway

t0

t24

t0

t24

t6

2-hydroxybutyrate (AHB)

Amino acid

-

-

N-acetylglycine

Amino acid

xylose

Carbohydrate

-

-

malate

Energy

-

-

10-nonadecenoate (19:1n9)

Lipid

-

-

2-hydroxypalmitate

Lipid

-

-

hexanoylcarnitine (C6)

Lipid

▲▲

▲▲

pregn steroid monosulfate

Lipid

-

-

3-hydroxybutyrate (BHBA)

Lipid

-

-

▲▲

▲▲

2-methylbutyroylcarnitine (C5)

Amino acid

3-indoxyl sulfate

Amino acid

-

-

5-oxoproline

Amino acid

-

-

histidine

Amino acid

-

-

isobutyrylcarnitine (C4)

Am ino acid

-

-

N-acetylornithine

Amino acid

-

-

tryptophan

Amino acid

-

-

threitol

Carbohydrate

-

-

phosphate

Energy

1-linoleoyl-GPC (18:2)

Lipid

-

-

1-oleoyl-GPC (18:1)

Lipid

-

-

2-palmitoyl-GPC (16:0)

Lipid

propionylcarnitine (C3)

Lipid

allantoin

Nucleotide

  1. Changes from the healthy baseline, t0,LPS: ▲/: less than two fold change; ▲▲/: more than two fold change, −: there was not a significant difference between SS or SNS groups). LPS, lipopolysaccharide; SNS, sepsis non-survivors; SS, sepsis survivors.